## Abstract ## Objective To develop valid instruments for the assessment of disease‐related damage and disease activity in Sjögren's syndrome (SS). ## Methods Data on 206 patients with primary SS were collected in 12 Italian centers. Each patient was scored by 1 investigator, on the basis of a g
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
✍ Scribed by Robert G. Knodell; Kamal G. Ishak; William C. Black; Thomas S. Chen; Robert Craig; Neil Kaplowitz; Thomas W. Kiernan; Jerome Wollman
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 490 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
A Histology Activity Index has been developed which generates a numerical score for liver biopsy specimens obtained from patients with asymptomatic chronic active hepatitis. Biopsies are graded in four categories: periportal necrosis, intralobular necrosis, portal inflammation, and fibrosis. Under code, three pathologists and three hepatologists evaluated 14 liver biopsy specimens obtained from five patients with asymptomatic chronic active hepatitis. Good correlation was seen between severity of liver biopsy lesions as judged by conventional histological descriptions and Histology Activity Index scores. Significant differences in Histology Activity Index score occurred in only 2 of 28 duplicate scorings of biopsy specimens by two observers. This system provides definitive endpoints for statistical analysis of serial changes in liver histology and offers an alternative to the use of conventional pathological descriptions in following the natural history and treatment responses of asymptomatic chronic active hepatitis. Chronic active hepatitis (CAH) is a necroinflammatory lesion of the liver diagnosed by characteristic pathologic changes in the liver biopsy specimen. Early reports of patients with CAH emphasized the profound clinical and biochemical alterations often accompanying this condition, described the poor prognosis associated with severe CAH, and outlined treatment regimens which significantly decreased mortality and morbidity (2-5). Recently it has become apparent that patients with severe CAH represent only a small percentage of the total population whose liver biopsy specimen is interpreted as showing CAH (6,7). Many such patients are totally free of clinical
📜 SIMILAR VOLUMES